Insilico Medicine has received FDA Orphan Drug Designation (ODD) for its AI-discovered drug (INS018_055) to treat rare chronic lung disease, Idiopathic Pulmonary Fibrosis (IPF)!
2023年1月18日
兩科企推健康管理平台 料3年內增逾百部自助配藥櫃
12 Jan 2022
AZ-CICC Healthcare Fund - a joint investment
12 Jan 2022
Who would’ve thought that as many as 81 types of gut microbiota are linked to Long COVID?
13 Oct 2022
Hong Kong’s next era fuelled by innovation
A Healthy Future
中大學者盧煜明奪美國「拉斯克獎」
科大發現阿爾茲海默症發病機制關鍵 有助研發更簡單安全治療策略
Fighting Alzheimer's disease: Hong Kong's Science and Technology Parks
應科院夥InnoHK眼視學中心 研AR治療視障者
Immuno Cure is making history as its newfound therapeutic vaccine for HIV has got approval from China's National Medical Products Administration (NMPA) to conduct phase 1 clinical trial!
HiFiBiO Therapeutics has received its 3rd FDA Investigational New Drug (IND) clearance, this time for its novel anti-BTLA monoclonal antibody (HFB200603) to target DIS™ selected solid tumours.
